Henlez

About

Disruptive treatment of follicular occlusion disorders

Develops potent, stable enzymes for topical application to treat dermatological conditions.

Primary focus is on acne-like disorders such as Acne vulgaris and Hidradenitis suppurativa.

Henlez is based in Copenhagen, Denmark and is headed by founder and CEO Jeppe Mouritsen

Henlez joined NOME in 2021.

Company

Visit website

Location

Denmark

Joined NOME

2021